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ABSTRACT Objective. To assess the feasibility of implementing a physician-based, patient-centered 
counseling intervention model in Ecuador to improve the ability of primary care physicians 
(PCPs) to reduce cardiovascular disease (CVD) risk factors among patients.
Methods. This was a randomized clinical trial conducted in primary care clinics in 
Quito in 2014 – 2016. Participants included 15 PCPs and their adult patients at high risk 
of developing type-2 diabetes. A physician-based and patient-centered counseling program 
was delivered to eight PCPs. Seven PCPs who did not receive the training comprised the 
control group. The patient experience was assessed by a patient exit interview (PEI). 
Assessment of the patient’s anthropometrics, blood pressure, and blood biochemistry param-
eters were conducted. Changes within and between groups were estimated utilizing chi-
square, ANOVA, paired t-tests, and coefficient with intervention. 
Results. A total of 197 patients participated, 113 in the intervention care group (ICG) and 
84 in the usual care group (UCG); 99 patients (87.6%) in the ICG and 63 (75%) in the UCG 
completed the study. Counseling steps, measured by the PEI, were significantly higher in the 
ICG (8.9±1.6 versus 6.6±2.3; P = 0.001). Comparison of the estimated difference between the 
ICG and the UCG showed greater decreases in HbA1c and total cholesterol in the ICG. Within 
the ICG, there were significant improvements in weight, BMI, HbA1C, total cholesterol, and 
LDL-cholesterol. 
Conclusions. Training PCPs in a patient-centered behavioral intervention for CVD risk 
factor reduction is feasible and efficacious for reducing CVD risk factors in Ecuador. Developed 
and developing countries alike could benefit from such an intervention.
Keywords Cardiovascular diseases; health human resource training; diabetes mellitus, type 2; 
cholesterol, HDL; cholesterol, LDL; blood pressure; Ecuador.
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Overweight and obesity are public 
health problems worldwide. Middle- 
income countries, such as Ecuador, are si-
multaneously experiencing the presence 
of both deficient and excess nutrition (1). 
It has been estimated that in developing 
countries, excess nutrition and diseases 
associated with it can have a greater 
 negative impact on morbidity and mortal-
ity than in developed countries (2). In re-
cent decades, the leading causes of death 
in Ecuador have included cardiovascu-
lar disease (CVD), type 2 diabetes, and 
 hypertension (3). 
In 2013, the Ministry of Public Health 
of Ecuador published the National Health 
and Nutrition Examination Survey. The 
results indicated that 62.8% of the adult 
population is overweight or obese (4) and 
that the prevalence of CVD risk factors is 
increasing. In addition, among adults 
over 50 years of age, approximately half 
are dyslipidemic, 22.7% have hyperten-
sion, 10.3% have diabetes, and 57.2% 
smoke cigarettes. Other metabolic condi-
tions associated with CVD are also 
 common in adults; prevalence rates of 
metabolic syndrome (27.7%) are higher 
than those reported for the adult popula-
tion of the United States (22.0%) in 2010. 
The same survey also indicated that 45% 
of adults are sedentary and that medica-
tion adherence is poor (48.9% reported 
not taking their medication). Moreover, 
type 2 diabetes, the primary cause of 
death in Ecuador, is a major risk factor for 
CVD (3).
According to the World Health Orga-
nization’s Alma-Ata principles, pri-
mary care should be a cornerstone of 
patient health care (5). Therefore, it is 
necessary to implement intervention 
strategies that help primary care physi-
cians (PCPs) and health care systems to 
decrease the prevalence of CVD risk 
factors in Ecuador. Intervention strate-
gies to decrease CVD risk factors need 
to consider the local context, including 
the characteristics of national health 
care systems and the knowledge and at-
titudes of patients (6). 
Previous work in the United States 
among Latino populations has demon-
strated the effectiveness of an interven-
tion model using physician-delivered, 
patient-centered counseling within a sup-
portive office environment to decrease 
CVD risk factors (7). That study showed 
that brief patient-centered nutrition 
counseling delivered by physicians com-
bined with office support can produce 
beneficial changes in patient diet, weight, 
and blood lipid concentrations. 
Consequently, the objective of the 
present study was to assess the feasibil-
ity of implementing a physician-based, 
patient-centered counseling intervention 
model in Ecuador to improve the ability 
of PCPs to reduce CVD risk factors 
among their patients.
MATERIALS AND METHODS
Clinical sites selection
Clinical system networks in Quito 
were selected based on their willingness 
to participate; provision of care to large, 
middle- and low-income populations; 
and the availability of electronic medi-
cal records. Six health care systems that 
met these criteria were invited to partic-
ipate; four accepted: two private, one 
public, and one private/public. For the 
intervention care group (ICG), one pub-
lic and two private clinics from these 
health systems were randomly selected. 
In these, the PCPs were trained on pa-
tient-centered counseling methods and 
received office system prompts for de-
livering the intervention. For the usual 
care group (UCG), one private, one pub-
lic, and one private/public clinic were 
randomly selected. In these, PCPs con-
tinued their usual practice. Primary care 
physicians and internists that were 
 regularly working in the clinics were in-
vited to participate. A total of 15 physi-
cians participated, eight in the ICG and 
seven in the UCG.
Training on nutrition, physical 
activity, and statin use 
Training of physicians in the ICG 
 included an intensive 4-hour session 
comprising a didactic component on the 
relationship between behavior and CVD 
risk factors and a review of the guide-
lines for statin therapy. Physicians re-
ceived a training binder with copies of 
the lecture slides, the counseling inter-
vention algorithms, a sample counseling 
script, and other intervention materials 
(diet and exercise goal sheets, the Diet 
and Physical Activity Risk Assessment 
[DARA] guide, and the statin use algo-
rithm, patient education materials, and 
a step counter). Subsequently, physicians 
were introduced to patient-centered 
counseling, its algorithms, and the statin 
use algorithm per the current guidelines 
for the United States (8, 9). Since there are 
no local guidelines for statin use, most 
physicians follow the United States or 
European guidelines. Physicians in the 
ICG were also taught to implement a 
7 – 10-minute patient-centered counsel-
ing protocol that included information 
on the benefits of walking and other easy 
physical activities, as well as dietary 
counseling, particularly reducing the 
consumption of simple carbohydrates, 
saturated fat, and salt, and increasing 
consumption of fruits and vegetables. 
To evaluate the physicians’ changes in 
attitudes and knowledge on physical ac-
tivity, diet, and lipid therapy, and any 
improvements in counseling skills, pre- 
and post-training assessments using a 
previously validated instrument were 
conducted among the ICG (7). Physi-
cians were taught to use the office sup-
port materials with their patients through 
live examples followed by role-playing 
with fellow PCPs who alternating roles 
as clinician, patient, and observer. Fur-
ther practical reinforcement training was 
carried out by a member of the research 
team in the physicians’ offices. 
During the 6 months of the study, phy-
sicians in the ICG delivered the interven-
tions using a package affixed to each 
study patient’s chart. The office support 
included a folder containing: the patient’s 
most recent lipid levels with a prompt 
highlighting the direct low density 
 lipoprotein cholesterol (LDL-C) value, a 
completed DARA questionnaire (for the 
initial visit only), DARA guide, dietary 
goal sheets to use with the patient, the 
counseling algorithm, and a copy of the 
national cholesterol management guide-
lines. Clinic personnel, along with the 
support of the research team, tracked 
 patients due for visits. 
Pre-eligibility and patient selection
Study participants were selected using 
the clinic’s patient appointment database. 
A recruitment call list was generated as 
needed, screening for patient age and 
body mass index (BMI) criteria (age ≥ 
30 years and BMI ≥ 25). Those identified 
received a pre-screening recruitment by 
telephone to verify age, BMI, and statins 
use. Patients taking lipid-lowering medi-
cations, those with known coronary heart 
disease, and those with secondary causes 
of hyperlipidemia were excluded.
Members of the research team made the 
pre-eligibility screening telephone calls. 
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When a pre-eligible patient showed in-
terest in participating, a fasting screening 
appointment was scheduled. Partici-
pants that accepted screening received a 
study identification code and were regis-
tered in the tracking database. 
Screening assessment
The day before the screening appoint-
ment, participants were reminded of the 
visit and the required overnight fasting. 
At the appointment, research staff veri-
fied the patient’s eligibility and obtained 
their informed consent. A venous blood 
sample was taken to measure: glucose 
and a complete lipid profile (total choles-
terol [Total-C]; direct LDL-C, high den-
sity lipoprotein cholesterol [HDL-C]; and 
triglycerides). Height and weight were 
measured with light clothing and no 
shoes. Blood pressure was measured af-
ter 10 minutes of rest. The clinic coordina-
tor then calculated the risk of developing 
type 2 diabetes using the Stern formula 
(10), notifying each patient of their eligi-
bility and sharing the laboratory results 
with their physician. 
Eligible patients were scheduled to re-
turn for a baseline physician visit. Prior to 
the baseline visit, the coordinator asked 
the clinical laboratory to complete the 
 determinations of glycated hemoglobin 
(HbA1c), AST, and ALT, and to store se-
rum samples for insulin determinations. 
All insulin samples were assayed in a sin-
gle batch at the end of the study.
Baseline visit with a physician
Twenty-four hours before the baseline 
appointment, patients were reminded 
of the visit. Before the physician’s con-
sultation, each participant provided a 
definitive informed consent. The clinic 
coordinator administered the DARA 
questionnaire, which was used for the 
physician’s counseling with each patient. 
Patients also completed a baseline sur-
vey that included sociodemographic 
 information, diet and physical activity, 
family history of chronic diseases, and 
use of alcohol. Within the diet section, 
there were 10 questions regarding con-
sumption of fruits and vegetables, and 17 
questions related to fat consumption. To 
quantify fat and fruits/vegetables con-
sumption, a score was applied based on 
previous studies (7). Finally, the research 
staff administered a depression screen-
ing to each participant using the Center 
for Epidemiologic Studies Depression 
Scale (11, 12). A score ≥ 16 was reported 
to the patient’s physician since it indi-
cates being at high risk for depression.
Appointments with the physician 
lasted approximately 20 minutes. After 
this baseline visit, patients were met by 
a research staff member who adminis-
tered the “Patient Exit Interview” (PEI) 
to evaluate how well the physician had 
followed the 12 patient-centered coun-
seling steps (7).
6-month assessment visit
The clinic coordinator scheduled a 
30-minute appointment 6 months after 
the baseline clinical visit and reminded 
each patient to fast overnight before the 
visit. The day of the appointment, the 
clinic coordinator administered the same 
assessment instruments as in the base-
line visit, except for the DARA. The pa-
tient’s weight and blood pressure were 
measured. A question regarding medica-
tion compliance was included in the final 
survey; it asked for the number of days 
per week that the patient complied with 
prescribed medication. A blood sample 
was also obtained to determine the same 
biochemical parameters measured at 
baseline. Patients received a US$ 6 incen-
tive after each study visit.
Anthropometric measurements
Anthropometric measurements were 
taken at the baseline visit and at the 
6-month follow-up visit. Weight and 
height were recorded by trained staff 
 using standardized techniques and cali-
brated equipment (13). For weight mea-
surement, an electronic SECA® 213 scale 
(Seca GmbH & Co., Hamburg, Ger-
many); for height measurement, a verti-
cally-mounted SECA® 213 stadiometer 
was used. Height was measured to the 
nearest 1.0 cm.
Blood samples
Qualified staff obtained venous blood 
samples from patients in the morning 
(after overnight fasting). Samples 
(plasma and serum) were centrifuged 
within 2 hours and processed immedi-
ately,  except for insulin, which was mea-
sured in all samples at the end of the 
study  period. Each patient was assigned 
a unique bar-code identification to accu-
rately trace samples (4).
Glucose, lipid profile, glycated 
hemoglobin, and insulin 
measurements
Blood glucose, total-C, direct LDL-C, 
HDL-C, and triglycerides were deter-
mined on a COBAS 6000-E601 
( Hitachi High-Technologies Corporation 
/  Minati-ku, Tokyo, Japan) using stan-
dard reagents (Roche Diagnostics GmbH, 
Mannheim, Germany). Serum insulin 
was determined using an electro-chemi-
luminescence immunoassay following 
the manufacturer’s instructions (Roche 
Diagnostics GmbH, Mannheim, Ger-
many) and chemiluminescent emission 
was measured using a fully automated 
analyzer system, the COBAS 6000 E601. 
Glycated hemoglobin was determined 
by immunoturbimetry/Acs anti-HbA1c, 
using the COBAS 6000 E601 according to 
the manufacturer’s instructions. Blood 
biochemistry analyses were conducted at 
NetLab (Quito, Ecuador), a laboratory 
certified by the College of American Pa-
thologists and the Brazilian Society of 
Clinical Pathologists (14).
To calculate the homeostasis model 
assessment-estimated insulin resistance 
(HOMA), the study utilized a modified 
formula by Wallace and colleagues—
fasting plasma glucose (mg/dL) multi-
plied by fasting serum insulin (mU/ml), 
divided by 405 (14).
Ethics
The Institutional Review Boards of 
the University of Massachusetts Medical 
School (Worcester, Massachusetts, United 
States) and Universidad de Las Américas 
(Quito, Ecuador) approved the study each 
year. The study followed the ethical stan-
dards of the Declaration of Helsinki (15).
Statistical analyses
Sample size was estimated by consider-
ing PEI scores with a standard deviation 
(SD) obtained by the authors from previ-
ous studies among a Latino population in 
Massachusetts, United States. A PEI score 
difference of 2 points±2.9 was used. 
 Considering this study’s design and an 
estimated intra-cluster correlation value 
for PEI of 0.3 per the Worcester Area 
Trial for Counseling in Hyperlipidemia 
(WATCH) study (7), a sample of 200 sub-
jects provided 84% power; thus, patients 
were assigned to each of the two study 
groups at a ratio of 1:1. 
4 Rev Panam Salud Publica 42, 2018
Original research Baldeón et al. • Training to reduce cardiovascular risk factors in Ecuador
Descriptive statistics were calculated 
for continuous variables; frequencies and 
percentages were calculated for categori-
cal variables. Analyses were performed 
with intention to treat. Differences be-
tween groups were assessed with chi-
square test and ANOVA. Differences 
within groups were assessed with paired 
t-test or the corresponding non-paramet-
ric statistics. Coefficient with interven-
tion, which is the estimated difference 
between the ICG and the UCG according 
to the change in the measured biochemi-
cal parameter, was calculated. Adjusted 
analyses were carried out that accounted 
for the patient clustering within physi-
cians at the individual sites (to account 
for correlations of patients treated by in-
dividual physicians). 
Mean differences between the ICG and 
the UCG for PEI score, anthropometric 
and blood pressure measures, and blood 
biochemistry parameters were estimated 
and tested using mixed effects linear re-
gression models with physician as a ran-
dom effect. This is a method suggested by 
Donner and Klar (16). Statistical analyses 
were performed with SAS® v9.4 software 
(Armonk, New York, United States). 
 Descriptive statistics are presented as 
means and SD, and P < 0.05 was consid-
ered to be statistically significant. 
RESULTS
Data were analyzed by simple, unad-
justed comparisons, as well as by con-
sidering the clustered study design. 
Since the outcome of both types of anal-
yses were similar and the conclusions 
were the same, only the results of the 
unadjusted analysis are presented here.
The study period lasted from October 
2014 – July 2016, with the 6-month 
 follow-up visits being held from April 
2015 – July 2016. Initially, 1 397 patients 
that met eligibility criteria (age and BMI) 
were approached through a telephone 
call (Figure 1). Of these, 1 172 were ex-
cluded because they declined to partici-
pate, did not come to the appointment, 
were not accessible, or did not meet the 
definitive eligibility criteria. The 225 pa-
tients who were eligible according to the 
Stern formula were allocated to the ICG 
(n = 125) and the UCG (n = 100). How-
ever, only 113 patients in the ICG and 
84 in the UCG attended the baseline phy-
sician appointment. Of these, 99 patients 
in the ICG and 63 in the UCG completed 
the study (Figure 1).
Patient characteristics at baseline
A total of 197 patients were included 
in the study, 138 (70%) women and 
59 (30%) men. At baseline, ICG and 
UCG were similar in age, gender, mari-
tal status,  employment, family income, 
and the proportion of first-degree rela-
tives with type 2 diabetes. However, 
educational level was higher in the 
ICG (UCG 6±3.1 versus ICG 7.4±3.7; 
P = 0.006). Also, at baseline both treat-
ment groups were similar in clinical 
and blood biochemical variables, except 
for HbA1c which was higher in the ICG 
(Table 1). 
Physicians’ attitudes before and 
after training
After counseling training, PCPs 
scored significantly better in their atti-
tudes  toward providing advice on phys-
ical  activity, diet, and lipid therapy 
(from 14.5±4.1 to 11.0±2.1 in a reverse 
scale; P < 0.05).
Feasibility of a patient-centered 
counseling program
To evaluate patient perception of PCPs 
regarding the behavioral counseling 
 intervention, a PEI was done after the 
baseline visit. As expected, physicians in 
the ICG delivered a significantly higher 
number of counseling steps than those in 
the UCG, 8.5±2.0 versus 6.1±2.6, respec-
tively. Counseling steps regarding diet, 
physical activity, and the prescription of 
lipid-lowering medication were ad-
dressed significantly more often within 
the ICG than the UCG (Table 2).
Changes in diet, physical activity, 
and depression
Changes in healthy dietary behaviors 
were recorded using the Block Dietary 
FIGURE 1. Flowchart of data analyzed to evaluate the impact that behavioral 
counseling training of primary care physicians has on reducing cardiovascular risk 
factors in Ecuador
Source: Prepared by the authors from the study results.
Enrollment
Assessed for eligibility
(n = 1397)
Randomized (n = 225)
Excluded (n = 1172)
Did not show for the visit (n = 611)
Not able to contact the patient (n = 463)
Not meeting inclusion criteria (n = 23)
Declined to participate (n = 41)
Other reasons (n = 34)
Allocated to usual care (n = 100)
Received allocated care (n = 84)
Did not receive allocated care (n = 16)
  Did not attend the appointment = 3
  Not able to contact the patient = 6
  Declined to participate = 4
  Other reasons = 3
Allocated to intervention (n = 125)
Received allocated intervention (n = 113)
Did not receive allocated intervention (n = 12)
    Did not attend the appointment = 9
    Not able to contact the patient = 2
    Declined to participate = 1
Intervention care Usual care
Analyzed (n = 63)
Analyzed (n = 99)
  Not able to draw sample = 1
  Not attended to the appoinment = 1
Analysis
Follow-up
Allocation
Lost to follow-up (n = 21)
  Attended by different health provider = 1
  Did not attend the appointment = 6
  Not able to contact the patient = 2
  Other = 3
  Physician dropped the study = 9
Lost to follow-up (n = 12)
  Attended by different health provider = 2
  Did not attend the appointment = 7
  Not able to contact the patient = 2
  Other = 1
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Fat Screener and Block Fruit/Vegetable 
screeners (15); physical activity was 
recorded using the Women’s Health 
Initiative Physical Activity Questions 
(17, 18). Patients in the ICG reduced the 
amount of fat intake from baseline to the 
end of the study, from a score of 17.2±7 to 
14.3±7 (P = 0.005), while patients in the 
UCG did not significantly change their 
fat intake (P = 0.756). There were no sig-
nificant differences in the consumption 
of fruits and vegetables, either between 
or within treatment groups. Regarding 
physical activity, both treatment groups 
presented a low-moderate physical ac-
tivity, and this was comparable through-
out the study period. In addition, at 
baseline the prevalence of patients at 
high risk for depression was higher in 
the ICG than in the UCG (56.3% versus 
32.9%; P = 0.001); however, this differ-
ence decreased by the end of the study 
and was not statistically significant 
(45.1% versus 33.9%).
Changes in anthropometric 
parameters and blood pressure
Comparison between treatment groups 
showed that there were no significant 
 differences in BMI and weight, at either 
baseline or at the end of the study period. 
However, as shown in Table 3, there was 
a statistically significant decrease in BMI 
and weight in both treatment groups 
from baseline through the end of the 
study period. The mean change was 
greater in the ICG.
Blood pressures, both systolic and dia-
stolic, were comparable between groups 
at baseline and at the end of the study 
TABLE 1. Baseline anthropometric and biological parameters of treatment groups in 
a study of the impact that behavioral counseling training of primary care physicians 
has on reducing cardiovascular risk factors in Ecuador
Demographic characteristicsa Usual care group Intervention group P value
BMI (kg/m2) 31.8±4.8
(n = 83)
32.2±4.9
(n = 113)
0.596
Weight (kg) 79.8±14.2
(n = 83)
79.0±14.8
(n = 113)
0.710
SBP (mmHg) 122.2±13.5
(n = 83)
122.6±15.5
(n = 112)
0.850
DBP (mmHg) 79.4±11.2
(n = 83)
79.8±13.1
(n = 112)
0.826
Glucose (mg/dL) 104.1±22.9
(n = 84)
101.5±28.2
(n = 113)
0.495
HbA1C (%) 6.0±1.1
(n = 80)
6.4±1.3
(105)
0.023
TC (mg/dL) 206.6±34.0
(n = 84)
209.7±37.8
(n = 113)
0.553
LDL (mg/dL) 129.4±29.6
(n = 82)
129.0±30.6
(n = 105)
0.921
HDL (mg/dL) 43.0±10.6
(n = 84)
42.9±10.5
(n = 113)
0.968
TG (mg/dL) 178.9±94.8
(n = 84)
200.3±129.3
(n = 112)
0.201
Insulin 21.1±23.3
(n = 45)
18.6±10.1
(n = 83)
0.394
HOMA 5.7±8.8
(n = 45)
4.5±2.5
(n = 83)
0.246
a BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; HbA1C = glycosylated 
hemoglobin; TC = total cholesterol; LDL = low-density lipoprotein-cholesterol; HDL = high-density lipoprotein-cholesterol; 
TG = triglycerides; HOMA = Homeostasis Model Assessment.
Source: Prepared by the authors from the study results.
TABLE 2. Mean score of behavior counseling steps discussed by the primary care physician (PCP) according to the patient exit 
interview (PEI), by treatment group, in a study of PCP training to reduce cardiovascular risk factors in Ecuador
Steps discussed or taken by the PCP Overall (%)
Intervention care group Usual care group
P valuea
(%) (%)
1. Cholesterol 175/192 (91.1) 103/111 (92.8) 72/81 (88.9) 0.442
2. Diet-cholesterol connection 183/193 (94.8) 109/112 (97.3) 74/81 (91.4) 0.098
3. Recommended dietary change to lower cholesterol 176/192 (91.7) 107/111 (96.4) 69/81 (85.2) 0.007
4. Past efforts to lower cholesterol 100/189 (52.9) 76/111 (68.5) 24/78 (30.8) 0.000
5. Problems making dietary changes 92/187 (49.2) 62/109 (56.9) 30/78 (38.5) 0.017
6. Solutions to the problems 94/102 (92.2) 61/64 (95.3) 33/38 (86.8) 0.145
7.  Made an agreement with patient on specific dietary changes or goals 169/190 (88.9) 103/110 (93.6) 66/80 (82.5) 0.019
8. Provided or sent nutrition materials to patient 126/192 (65.6) 109/112 (97.3) 17/80 (21.3) 0.000
9. Referred patient for nutrition counseling 22/192 (11.5) 11/111 (9.9) 11/81 (13.6) 0.494
10. Planned future visit to address cholesterol 127/193 (65.8) 81/112 (72.3) 46/81 (56.8) 0.031
11. Prescribed medication to lower cholesterol 34/193 (17.6) 28/112 (25.0) 6/81 (7.4) 0.000
12. Discussed beginning or continuing exercise 171/190 (90.0) 108/110 (98.2) 63/80 (78.8) 0.000
Group No. of patients Mean PEI score ±SD
Intervention care 113 8.5±2.0
Usual care 84 6.1±2.6
Total 197 7.5±2.5
a P < 0.0001 (ANOVA).
Source: Prepared by the authors from the study results.
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period. However, in the UCG there was 
a significant decrease in systolic blood 
pressure from baseline until the end of 
the study (Table 3). 
Changes in blood biochemical 
parameters
As indicated above, baseline compar-
ison between treatment groups showed 
that serum concentrations of HbA1c 
were significantly lower in the UCG. 
 After 6 months of intervention, the CWI 
was estimated; this CWI is the estimated 
difference between ICG versus UCG ac-
cording to the change in the measured 
biochemical parameter. There were no 
statistical differences in CWI for serum 
glucose, direct LDL-C, HDL-C, triglyc-
erides, and insulin between the groups. 
However, there were statistically greater 
decreases for HbA1c and Total-C in the 
ICG than in the UCG. 
Assessment of changes within groups 
showed that in the UCG, only serum 
concentrations of direct LDL-C signifi-
cantly decreased from baseline to the 
end of the study period ( -7mg/dL). 
However, in the ICG there were signifi-
cant decreases in serum concentra-
tions of HbA1c, Total-C, and direct 
LDL-C ( Table 4). Patients in the ICG 
were significantly more likely to receive 
lipid-lowering medications than the 
UCG, 25.0% versus 7.4% respectively 
(P = 0.001). In the ICG, 19 patients re-
ceived statins and 6 received fibrates; 
whereas in the UCG, none received sta-
tins, 5 received fibrates, and 1 received 
an inhibitor of protein convertase subtili-
sin/kexin type 9. Further analysis con-
sidering only the individuals that did not 
receive statin treatment showed that 
 patients in the ICG improved their serum 
LDL concentrations from 125.8±26.1 to 
122.0±33.0 (P = 0.001). However, patients 
who did not receive statins in the UCG 
decreased their serum LDL concentra-
tions, from 127.7±30.7 to 121.0±30.4; 
however, this decrease was not statisti-
cally significant, (P = 0.057).
TABLE 4. Comparison in blood biochemistry parameters, within treatment groups, at baseline and 24 weeks after the intervention 
to reduce cardiovascular risk factors through behavioral counseling in Ecuador
Parametersa
Usual care group
Mean change P value
Intervention care group
Mean change P value
Baseline Final Baseline Final
Glucose 100.3±12.7
n = 63
97±16.8
n = 63
-3.27 0.087 101.7±30.9
n = 92
101.5±13.4
n = 92
-0.16 0.951
HbA1C 5.9±1.1
n = 59
5.9±0.7
n = 59
-0.04 0.772 6.5±1.4
n = 81
5.8±0.5
n = 81
-0.72 0.000
TC 203.4±34.4
n = 63
198.1±33.5
n = 63
-5.29 0.129 210.1±38.1
n = 92
194.6±41.5
n = 92
-15.47 0.000
LDL 126.7±29.9
n = 60
119.7±29.9
n = 60
-6.98 0.033 129.7±29.9
n = 82
115.5±35.5
n = 82
-14.21 0.001
HDL 42.6±10.5
n = 63
43.7±12.6
n = 63
+1,06 0.347 43.1±10.3
n = 91
42±11.2
n = 91
-1.11 0.165
TG 171.3±95.5
n = 63
180.3±106.5
n = 63
+8.97 0.326 193.8±111.4
n = 91
181.1±105.4
n = 91
-12.65 0.136
Insulin 19.8±20.4
n = 61
25.9±29.4
n = 59
+6.1 0.667 18.7±9.9
n = 95
20.6±20.4
n = 71
+1.9 0.228
HOMA 5.3±7.6
n = 61
7.0±11
n = 59
+1.7 0.396 4.6±2.5
n = 95
5.4±6
n = 67
+0.8 0.305
a HbA1C = glycosylated hemoglobin; TC = total cholesterol; LDL = low-density lipoprotein-cholesterol; HDL = high-density lipoprotein-cholesterol; TG = triglycerides; HOMA = Homeostasis 
Model Assessment.
TABLE 3. Changes in anthropometric parameters and blood pressure, by treatment group, at baseline and 24 weeks after the 
intervention to reduce cardiovascular risk factors through behavioral counseling in Ecuador
Parametersa
Usual care group Intervention care group
Baseline Final Mean change P value Baseline Final Mean change P value
BMI 31.9±4.8
n = 54
31.6±4.9
n = 54
-0.36 0.035 32.5±5.1
n = 96
31.7±4.9
n = 96
-0.77 0.002b
Weight 80.0±14.0
n = 54
79.1±14.1
n = 54
-0.91 0.029 78.7±14.5
n = 96
76.9±14.4
n = 96
-1.79 0.005b
SBP 122.7±13.8
n = 58
118±9.7
n = 58
-4.64 0.024b 122.3±14.4
n = 97
120±16.9
n = 97
-2.26 0.215
DBP 78.9±11.2
n = 58
79±7.1
n = 58
+0.02 0.990 80.7±10.8
n = 98
78.8±14.3
n = 97
-1.9 0.262
a BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure.
b Statistically significant.
Source: Prepared by the authors from the study results.
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Comparison of medication 
compliance
Self-reported patient medication com-
pliance was also evaluated. Results 
showed that 98.3% of patients in the 
ICG took medication as prescribed 
5 – 7 days per week, while only 86.7% of 
patients in the UCG did so in the same 
period of time (P = 0.042).
DISCUSSION
This study demonstrated that it is 
 possible to implement an effective pro-
gram to decrease CVD risk factors in 
private and public primary care clinics 
in Quito through an intervention of 
physician-based, patient-centered coun-
seling with office support. Most partici-
pating PCPs had a favorable attitude 
towards the study. PCPs from the ICG 
more frequently performed the counsel-
ing steps and followed the guidelines 
to decrease CVD risk factors in their 
 patients. In  addition, we observed that 
patients in the ICG significantly de-
creased their fat  consumption and risk 
of depression, and improved their 
weight, BMI, HbA1c,  Total-C, and direct 
LDL-C.
Previous work has shown that lipid 
management programs facilitated dur-
ing physician visits result in a decrease 
in CVD risk factors. Our previous work, 
WATCH (7), in Massachusetts, evalu-
ated the efficacy of an intervention 
of physician-delivered patient-centered 
counseling with office support, showing 
significant beneficial changes in patient 
diet, weight, and blood lipid levels after 
1 year. In that study, patients attended 
by physicians who had received the be-
havioral counseling training had lower 
saturated fat intake (10.3% decrease), a 
reduction in body weight (2.3 kg), and a 
decrease in LDL-C (3.8 mg/dL). In the 
present study, physician training plus 
office support also resulted in reduced 
fat intake and weight, similar to that 
seen in the WATCH study; and the de-
crease in body weight (ICG -1.8 versus 
UCG -0.91 kg/m2) also resulted in a sig-
nificant BMI decrease, greater than that 
observed by WATCH. 
In addition, in the current study, pa-
tients in the ICG had lower blood 
HbA1c, Total-C, and direct LDL-C by the 
end of the intervention. A significant re-
duction of direct LDL-C was observed in 
the ICG regardless of statin use, al-
though the reduction seen in those on 
statins was greater. It is noticeable that 
none of the subjects in the UCG re-
ceived statins,  although all subjects were 
overweight or obese and were at risk of 
developing diabetes. A study that as-
sessed the use of effective therapies in 
individuals with a history of coronary 
heart disease or stroke in South America 
showed that an important proportion 
did not receive any proven therapy (19). 
In the present study, we saw a similar 
phenomenon in the UCG where statin 
therapy was not used. Potential barriers 
to treatment access in settings similar 
to Ecuador include the high cost and 
lack of medicines, and limited access to 
health care and specialists; other vari-
ables affecting treatment adherence and 
health care attendance are good commu-
nication and trust between patients and 
physicians (6). Interventions to improve 
physicians’ capacity to counsel patients 
could contribute to closing the gaps in 
the use of proven medications and im-
proving health care provision. 
Together, these results indicate that 
implementation of an intervention of 
physician-delivered, patient-centered 
counseling with office support is feasible 
in Ecuador, and that methodologies 
originally developed for a United States 
population are equally applicable to a 
country on a different point of the socio-
economic continuum.
The current project was primarily a 
feasibility study, and is in many ways 
different from the larger WATCH study 
(7). Fifteen physicians and 197 patients 
from 4 different clinical systems partici-
pated in the present study, while 45 
PCPs and 1 162 patients from 12 separate 
patient care units were part of the 
WATCH trial. In the WATCH study, 
identification of an at-risk population 
was determined by abnormal lipid pro-
files, while in the current report individ-
uals with increased risk to develop 
diabetes using the Stern estimation was 
used as the inclusion criterion. The indi-
cated eligibility criteria for both studies 
could have resulted in a different profile 
of patients regarding CVD risk factors. 
The intervention lasted 6 months in the 
present study and 1 year in the WATCH 
study. However, physician training and 
the components of the patient-centered 
counseling model with office support 
were similar for the two studies. These 
two studies show that physician training 
and the tools used are effective for de-
creasing CVD risk factors in at-risk pop-
ulations. These results  encourage the 
implementation of larger studies with 
similar intervention methodologies in 
developing countries where cardiovas-
cular diseases are major public health 
problems. 
Limitations. As indicated, this feasi-
bility study was carried out with a lim-
ited number of PCPs and clinics that 
could have specific administrative and 
health care provision characteristics, 
which could limit the generalizabil-
ity of current results. Also, a follow up 
of 6 months could be an insufficient 
time to generate recommendations for 
the implementation of this educational 
intervention. 
Conclusions
Training PCPs in a patient-centered 
behavioral intervention for CVD risk fac-
tor reduction is feasible and efficacious. 
The present intervention aligns with Al-
ma-Ata principles that highlight the im-
portant role of a comprehensive primary 
care strategy to improve public health 
care. Implementation of this educational 
strategy could be an important public 
health measure to reduce cardiovascular 
disease. 
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RESUMEN Objetivo. Evaluar la factibilidad de implementar un modelo de intervención en el 
médico y centrado en el paciente en Ecuador a fin de mejorar la capacidad de los médi-
cos de atención primaria (MAP) para reducir los factores de riesgo de enfermedades 
cardiovasculares (ECV) en los pacientes.
Métodos. Se llevó a cabo un ensayo clínico aleatorio en consultorios de atención pri-
maria en Quito entre el 2014 y el 2016. Participaron 15 MAP y sus pacientes adultos 
con riesgo alto de padecer diabetes de tipo 2. Se proporcionó un programa médico 
orientativo centrado en el paciente a ocho MAP. Los siete que no recibieron la capaci-
tación fueron el grupo testigo. Se evaluó la experiencia de los pacientes por medio de 
una encuesta de salida a los pacientes. Se evaluaron las medidas antropométricas, la 
presión arterial y los parámetros bioquímicos sanguíneos del paciente. Se calcularon 
los cambios entre los grupos y dentro de ellos por medio de pruebas de ji cuadrado, 
análisis de la varianza, pruebas t pareadas y coeficiente con intervención.
Resultados. En total participaron 197 pacientes, 113 en el grupo de atención con 
intervención (GAI) y 84 en el grupo de atención habitual (GAH); 99 pacientes (87,6 %) 
en el GAI y 63 (75 %) en el GAH completaron el estudio entre el 2014 y el 2016. Los 
pasos de orientación, según los resultados de la encuesta de salida, fueron significati-
vamente mayores en el GAI (8,9±1,6 frente a 6,6±2,3; P = 0,001). Al comparar la dife-
rencia estimada entre el GAI y el GAH, se encontraron mayores reducciones de HbA1c 
y del colesterol total en el GAI. Dentro del GAI, se encontraron mejoras considerables 
en el peso, IMC, HbA1C, colesterol total y C-LDL.
Conclusiones. La capacitación de los MAP mediante una intervención sobre el com-
portamiento centrada en el paciente para reducir los factores de riesgo de ECV es fac-
tible y eficaz para reducir los factores de riesgo de ECV en Ecuador. Los países desa-
rrollados y en desarrollo podrían beneficiarse por igual de tal intervención.
Palabras clave Enfermedades cardiovasculares; capacitación de recursos humanos en salud; diabetes 
mellitus tipo 2; HDL-colesterol; LDL-colesterol; presión sanguínea; Ecuador.
Repercusión de la 
capacitación de médicos 
de atención primaria 
en orientación sobre el 
comportamiento para reducir 
los factores de riesgo 
de sufrir enfermedades 
cardiovasculares en Ecuador
RESUMO Objetivo. Avaliar a viabilidade de implementar um modelo de intervenção do tipo 
orientação comportamental dirigida ao médico e centrada no paciente para melhorar 
a capacidade dos profissionais da atenção primária de reduzir os fatores de risco de 
doenças cardiovasculares nos pacientes.
Métodos. Estudo clínico randomizado conduzido em ambulatórios de atenção pri-
mária em Quito, no Equador, de 2014 a 2016. Participaram do estudo 15 médicos da 
atenção primária e os respectivos pacientes adultos com alto risco de diabetes tipo 2. 
Oito participantes fizeram parte de uma intervenção do tipo orientação comporta-
mental dirigida ao médico e centrada no paciente. Os outros sete médicos fizeram 
parte do grupo de controle que não recebeu a capacitação. A experiência do paciente 
foi avaliada com uma entrevista de saída. Características antropométricas, medidas de 
pressão arterial e parâmetros bioquímicos foram avaliados nos pacientes. As mudan-
ças dentro de um mesmo grupo e entre os grupos foram estimadas com o uso do teste 
do qui-quadrado, ANOVA, teste t pareado e coeficiente com intervenção.
Resultados. Participaram do estudo 197 pacientes ao todo, sendo 113 no grupo de 
intervenção (GI) e 84 no grupo de atenção de rotina (GR), e completaram o estudo 99 
pacientes (87,6%) no GI e 63 (75%) no GR em 2014–2016. O GI recebeu um número 
significativamente maior (8.9±1.6 vs. 6.6±2.3; P = 0.001) de orientações, avaliadas na 
entrevista de saída. Uma comparação da diferença estimada entre o GI e o GR demons-
trou maior redução no nível de hemoglobina glicosilada (HbA1c) e colesterol total no 
GI. Os pacientes do GI tiveram melhora significativa no peso corporal, índice de massa 
corporal (IMC), colesterol total e LDL.
Conclusões. Capacitar os médicos da atenção primária em uma intervenção compor-
tamental centrada no paciente é uma opção viável e eficaz para reduzir os fatores de 
risco de doenças cardiovasculares no Equador. Ambos os países desenvolvidos e em 
desenvolvimento poderiam se beneficiar com esta intervenção.
Palavras-chave Doenças cardiovasculares; capacitação de recursos humanos em saúde; diabetes melli-
tus tipo 2; HDL-colesterol; LDL-colesterol; pressão sanguínea; Equador.
Impacto da capacitação 
de médicos da atenção 
primária em orientação 
comportamental para 
reduzir os fatores de 
risco de doenças 
cardiovasculares no 
Equador
